Friday, March 1, 2013
Transcept Pharmaceuticals Inc., of Point Richmond, Calif., reported a net loss of approximately $12 million for the 12 months ending Dec. 31, including a fourth-quarter net loss of approximately $6.6 million, compared to a net loss of approximately $3.9 million and net income of approximately $5.3 million, respectively, in the same periods the previous year.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.